AOD-9604 Explained: What the Research Says and Its ARTG Status

AOD-9604 Explained: What the Research Says and Its ARTG Status

AOD-9604 has a distinctive history among peptides, having originated from Australian research and undergone formal clinical trials. This article covers what class of substance it is, its research history, and how it’s regulated in Australia — for general educational purposes only.

What Is AOD-9604?

AOD-9604 is a modified fragment of human growth hormone, originally developed through Australian research and studied in formal clinical trials, including trials conducted in Australia. Despite this trial history, it did not proceed to registration as an approved therapeutic good for the indication originally studied. Its research history includes completed human clinical trials, though the overall program did not result in ARTG approval.

Regulatory Status in Australia

AOD-9604 is not listed on the Australian Register of Therapeutic Goods (ARTG) as an approved medicine. It has not been evaluated favourably by the Therapeutic Goods Administration (TGA) for approval, and it is not available for general retail sale.

Where an appropriately qualified, registered healthcare practitioner considers a compounded preparation clinically appropriate for an individual patient — based on their own independent clinical judgement — it may be prescribed and dispensed through a licensed Australian compounding pharmacy. This is an individual clinical decision, not a general approval or endorsement of the substance.

Why Individual Assessment Matters

Because AOD-9604 is not an approved, standardised therapeutic good, any decision about whether a compounded preparation might be appropriate rests entirely with an independent, registered healthcare practitioner, following a review of the individual’s medical history, current medications, and circumstances. Not every individual will be considered suitable, and a consultation does not guarantee that any prescription will be issued.

Common Questions

Is AOD-9604 approved for use in Australia? No. Despite undergoing clinical trials, it did not proceed to ARTG registration. Any access occurs only through individual prescription and compounding, at the discretion of a registered practitioner.

Can I buy AOD-9604 directly? No reputable, legal pathway allows direct-to-consumer sale of AOD-9604 as a therapeutic good in Australia.

What does the current research show? AOD-9604 has a more developed clinical trial history than many other peptides, including completed human trials. However, the trial program did not result in regulatory approval, and no conclusions about effectiveness or safety should be assumed on the basis of trial history alone.

Disclaimer

This article is for general educational purposes only and does not constitute medical advice, and is not a representation that AOD-9604 is safe, effective, or approved for any purpose. GL Vitality Drips operates as a consultation coordination and administrative support service only and does not provide, supply, or grant access to any therapeutic good, and does not diagnose, treat, or prescribe. All clinical decisions are made independently by registered healthcare practitioners following individual consultation and assessment. Where a prescription is issued, preparation occurs through a licensed Australian compounding pharmacy.

once.